https://www.biospace.com/merrimack-pharmaceuticals-inc-reports-fourth-quarter-2014-financial-results
Merrimack Pharmaceuticals Inc. Reports Fourth Quarter 2014 Financial Results - BioSpace
merrimack pharmaceuticals incfourth quarterfinancial resultsreports2014
https://www.biospace.com/merrimack-pharmaceuticals-inc-announces-initiation-of-a-phase-2-biomarker-selected-clinical-trial-of-mm-121-in-patients-with-heregulin-positive-non-s
Merrimack Pharmaceuticals Inc. Announces Initiation Of A Phase 2 Biomarker-Selected Clinical Trial...
merrimack pharmaceuticals inc
https://www.businesswire.com/news/home/20240509655112/en/Merrimack-Pharmaceuticals-Inc.-Announces-Anticipated-Final-Cash-Dividend-Amount-of-Initial-Liquidating-Distribution-Subject-to-Receipt-of-Stockholder-Approval-of-Plan-of-Dissolution
Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial...
Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt
merrimack pharmaceuticals inccash dividendannouncesanticipated
https://www.biospace.com/merrimack-pharmaceuticals-inc-announces-timing-of-fourth-quarter-2014-investor-conference-call
Merrimack Pharmaceuticals Inc. Announces Timing Of Fourth Quarter 2014 Investor Conference Call -...
merrimack pharmaceuticals inc